BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

233 related articles for article (PubMed ID: 22912849)

  • 1. Merlin is a negative regulator of human melanoma growth.
    Murray LB; Lau YK; Yu Q
    PLoS One; 2012; 7(8):e43295. PubMed ID: 22912849
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Merlin, a "magic" linker between extracellular cues and intracellular signaling pathways that regulate cell motility, proliferation, and survival.
    Stamenkovic I; Yu Q
    Curr Protein Pept Sci; 2010 Sep; 11(6):471-84. PubMed ID: 20491622
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The neurofibromatosis 2 tumor suppressor gene product, merlin, regulates human meningioma cell growth by signaling through YAP.
    Striedinger K; VandenBerg SR; Baia GS; McDermott MW; Gutmann DH; Lal A
    Neoplasia; 2008 Nov; 10(11):1204-12. PubMed ID: 18953429
    [TBL] [Abstract][Full Text] [Related]  

  • 4. NF2/merlin is a novel negative regulator of mTOR complex 1, and activation of mTORC1 is associated with meningioma and schwannoma growth.
    James MF; Han S; Polizzano C; Plotkin SR; Manning BD; Stemmer-Rachamimov AO; Gusella JF; Ramesh V
    Mol Cell Biol; 2009 Aug; 29(15):4250-61. PubMed ID: 19451225
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Merlin is a potent inhibitor of glioma growth.
    Lau YK; Murray LB; Houshmandi SS; Xu Y; Gutmann DH; Yu Q
    Cancer Res; 2008 Jul; 68(14):5733-42. PubMed ID: 18632626
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Merlin/NF2-Lin28B-let-7 Is a Tumor-Suppressive Pathway that Is Cell-Density Dependent and Hippo Independent.
    Hikasa H; Sekido Y; Suzuki A
    Cell Rep; 2016 Mar; 14(12):2950-61. PubMed ID: 26997273
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Merlin, a regulator of Hippo signaling, regulates Wnt/β-catenin signaling.
    Kim S; Jho EH
    BMB Rep; 2016 Jul; 49(7):357-8. PubMed ID: 27345717
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Merlin/NF2 regulates angiogenesis in schwannomas through a Rac1/semaphorin 3F-dependent mechanism.
    Wong HK; Shimizu A; Kirkpatrick ND; Garkavtsev I; Chan AW; di Tomaso E; Klagsbrun M; Jain RK
    Neoplasia; 2012 Feb; 14(2):84-94. PubMed ID: 22431917
    [TBL] [Abstract][Full Text] [Related]  

  • 9. p21-activated kinase links Rac/Cdc42 signaling to merlin.
    Xiao GH; Beeser A; Chernoff J; Testa JR
    J Biol Chem; 2002 Jan; 277(2):883-6. PubMed ID: 11719502
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Nf2 tumor suppressor, merlin, functions in Rac-dependent signaling.
    Shaw RJ; Paez JG; Curto M; Yaktine A; Pruitt WM; Saotome I; O'Bryan JP; Gupta V; Ratner N; Der CJ; Jacks T; McClatchey AI
    Dev Cell; 2001 Jul; 1(1):63-72. PubMed ID: 11703924
    [TBL] [Abstract][Full Text] [Related]  

  • 11. LIM domain kinases as potential therapeutic targets for neurofibromatosis type 2.
    Petrilli A; Copik A; Posadas M; Chang LS; Welling DB; Giovannini M; Fernández-Valle C
    Oncogene; 2014 Jul; 33(27):3571-82. PubMed ID: 23934191
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of Merlin/NF2 inactivation in tumor biology.
    Petrilli AM; Fernández-Valle C
    Oncogene; 2016 Feb; 35(5):537-48. PubMed ID: 25893302
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Angiomotin binding-induced activation of Merlin/NF2 in the Hippo pathway.
    Li Y; Zhou H; Li F; Chan SW; Lin Z; Wei Z; Yang Z; Guo F; Lim CJ; Xing W; Shen Y; Hong W; Long J; Zhang M
    Cell Res; 2015 Jul; 25(7):801-17. PubMed ID: 26045165
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Merlin, the NF2 gene product.
    Pećina-Šlaus N
    Pathol Oncol Res; 2013 Jul; 19(3):365-73. PubMed ID: 23666797
    [TBL] [Abstract][Full Text] [Related]  

  • 15. NF2/Merlin Inactivation and Potential Therapeutic Targets in Mesothelioma.
    Sato T; Sekido Y
    Int J Mol Sci; 2018 Mar; 19(4):. PubMed ID: 29587439
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Merlin/NF2 Suppresses Pancreatic Tumor Growth and Metastasis by Attenuating the FOXM1-Mediated Wnt/β-Catenin Signaling.
    Quan M; Cui J; Xia T; Jia Z; Xie D; Wei D; Huang S; Huang Q; Zheng S; Xie K
    Cancer Res; 2015 Nov; 75(22):4778-4789. PubMed ID: 26483206
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The neurofibromatosis type 2 gene product, merlin, reverses the F-actin cytoskeletal defects in primary human Schwannoma cells.
    Bashour AM; Meng JJ; Ip W; MacCollin M; Ratner N
    Mol Cell Biol; 2002 Feb; 22(4):1150-7. PubMed ID: 11809806
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characterization of chicken Nf2/merlin indicates regulatory roles in cell proliferation and migration.
    Chen Y; Gutmann DH; Haipek CA; Martinsen BJ; Bronner-Fraser M; Krull CE
    Dev Dyn; 2004 Mar; 229(3):541-54. PubMed ID: 14991710
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Regulation of mTOR complex 2 signaling in neurofibromatosis 2-deficient target cell types.
    James MF; Stivison E; Beauchamp R; Han S; Li H; Wallace MR; Gusella JF; Stemmer-Rachamimov AO; Ramesh V
    Mol Cancer Res; 2012 May; 10(5):649-59. PubMed ID: 22426462
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition of SIRT2 in merlin/NF2-mutant Schwann cells triggers necrosis.
    Petrilli A; Bott M; Fernández-Valle C
    Oncotarget; 2013 Dec; 4(12):2354-65. PubMed ID: 24259290
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.